{"nct_id":"NCT03539536","title":"Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2018-10-10","start_date_type":"ACTUAL","primary_completion_date":"2025-10","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}